Stanford University School of Medicine
Stanford, California, 94305, United States
NCT Number: NCT00756405
The aim of the Antioxidant Study was to compare the efficacy of foods naturally rich in antioxidants with that of antioxidants in a pill form on markers of inflammation and plasma cholesterol in healthy adults at risk of cardiovascular disease.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Stanford, California, 94305, United States
Increasing the amount of antioxidants in your diet is thought to be one way to improve your health. If antioxidants do have a beneficial effect, one way to measure that is to examine possible changes in the levels of inflammatory markers in your blood.
Participants were asked to consume an antioxidant supplement including carotenoids, mixed tocopherols, vitamin C and selenium, or a placebo for 8 weeks. The doses of antioxidants will be similar to the amounts suggested by the United States Department of Agriculture (USDA) recommended daily allowances (RDA). In addition, a group of participants will be asked to change their usual eating habits and consume more of certain foods that are naturally good sources of the four antioxidants contained in the pills.
Eligible participants were asked to come to the Stanford Campus for 3 fasting blood draws over the period of 8 weeks and to complete diet and physical activity questionnaires at the beginning, middle, and end of the study period.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Overweight/obesity; high LDL cholesterol, pre-hypertension.
Exclusion criteria
1. Daily intake of > 5 servings of vegetables and fruits 2. Fasting blood glucose >140 mg/dL 3. BMI >40 4. Liver or renal disease; Atherosclerosis (e.g., CAD, PAD); Malignant neoplasm; Ongoing infection; Inflammatory disease 5.Currently taking the following medications: Anti-inflammatory drugs Lipid lowering drugs Anti-hypertensive drugs Calcium containing drugs Drugs known to affect blood coagulation Drugs known to affect antioxidant status 6. Pregnant or lactating 7. Inability to communicate effectively with study staff
Participants were asked to increase antioxidant-rich food intake to approximately double their daily habitual intake and take a placebo pill.
Participants were asked to consume their usual diet and take a supplement containing carotenoids, mixed tocopherols, vitamin C and selenium, designed to approximately double their daily habitual intake.
Participants were asked to consume their usual diet and take a placebo pill.
Time frame: Baseline and 8 weeks
Change was calculated as the value at 8 weeks minus the value at baseline
Time frame: Baseline and 8 weeks
Blood concentrations of carotenoids, tocopherols, selenium, and vitamin C (to validate dietary change)
Time frame: Baseline and 8 weeks
Dietary intake of carotenoids, tocopherols, selenium, and vitamin C (as measured by 3-day dietary recalls)
Christopher Gardner
Other
Potential Health Benefits of Dietary Antioxidants From Supplements v. Foods
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06543706
Body Weight, Brain Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT01550432
Body Weight, Cardiovascular Diseases
Stanford, California, United States
View Trial DetailsNCT00381992
Acquired Immunodeficiency Syndrome, Bacterial Infections
Winston-Salem, North Carolina, United States
View Trial DetailsNCT00955903
Body Weight, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial Details